SICKLE CELL DISEASE
Clinical trials for SICKLE CELL DISEASE explained in plain language.
Never miss a new study
Get alerted when new SICKLE CELL DISEASE trials appear
Sign up with your email to follow new studies for SICKLE CELL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a cancer drug tame sickle cell pain?
Disease control TerminatedThis early-phase study tested the drug imatinib in 7 adults with sickle cell anemia who have frequent pain crises. Researchers wanted to see if imatinib could reduce sickling of red blood cells and lower pain episodes. The study was terminated early, so results are limited.
Matched conditions: SICKLE CELL DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Indiana University • Aim: Disease control
Last updated May 26, 2026 03:13 UTC
-
Sickle cell drug oxbryta under Real-World watch
Disease control TerminatedThis study followed 265 people with sickle cell disease who were taking the drug Oxbryta (voxelotor) to see how it worked in everyday life. Researchers measured changes in blood counts, organ function, and complications like pain crises over up to 5 years. The goal was to better …
Matched conditions: SICKLE CELL DISEASE
Sponsor: Pfizer • Aim: Disease control
Last updated May 26, 2026 03:11 UTC
-
Sickle cell drug safety study ends early
Disease control TerminatedThis study was designed to check the long-term safety of the drug GBT021601 (osivelotor) in people with sickle cell disease who had already taken it in a previous study. It included 47 participants aged 6 months and older. The study was terminated early, so results are limited.
Matched conditions: SICKLE CELL DISEASE
Phase: PHASE2, PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated May 26, 2026 03:11 UTC
-
Gene-Edited stem cells aim to tame sickle cell disease
Disease control TerminatedThis early-phase study tested a one-time treatment using the patient's own genetically modified stem cells to boost fetal hemoglobin, which can reduce painful crises and other severe complications of sickle cell disease. Only 4 participants were enrolled before the study was term…
Matched conditions: SICKLE CELL DISEASE
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 03:09 UTC
-
Sickle cell drug voxelotor safety checked in extension study
Disease control TerminatedThis study looked at the long-term safety of the drug voxelotor in 179 people with sickle cell disease who had already taken it in earlier studies. Participants continued taking the drug to monitor side effects and complications. The study was terminated early, but it provided in…
Matched conditions: SICKLE CELL DISEASE
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated May 26, 2026 03:08 UTC
-
Sickle cell drug trial in kids halted midway
Disease control TerminatedThis study tested a drug called voxelotor in children aged 2 to 15 with sickle cell disease who had slightly abnormal blood flow in their brains. The goal was to see if the drug could improve that blood flow and reduce stroke risk. The trial was stopped early, so results are limi…
Matched conditions: SICKLE CELL DISEASE
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Sickle cell drug inclacumab safety checked in long-term study
Disease control TerminatedThis study looks at the long-term safety of inclacumab in people with sickle cell disease who have already taken the drug in a previous study. It tracks side effects and how often pain crises happen. The goal is to see if the drug remains safe over time.
Matched conditions: SICKLE CELL DISEASE
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated May 18, 2026 12:07 UTC
-
Sickle cell drug voxelotor safety check ends early
Disease control TerminatedThis study looked at the long-term safety of the drug voxelotor in 162 people with sickle cell disease who had already taken it in earlier studies. The main goal was to track any side effects. The study was stopped early, but the results help doctors understand how safe voxelotor…
Matched conditions: SICKLE CELL DISEASE
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated May 18, 2026 12:00 UTC